AlphaStocks

ARWR vs HRMY

As of Sep 20, 2026, Arrowhead Pharmaceuticals (ARWR) scores 6.0/10 and Harmony Biosciences Holdings (HRMY) 7.5/10 on AlphaStocks' five-model composite, so HRMY scores higher.

ARWR

ARROWHEAD PHARMACEUTICALS, INC.

6.0

Consider Buy

$66.56

HRMY

Harmony Biosciences Holdings, Inc.

7.5

Strong Buy

$42.06

ARWR vs HRMY: Which is the Better Investment?

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) scores 6.0/10 while Harmony Biosciences Holdings, Inc. (HRMY) scores 7.5/10 on AlphaStocks' composite model. Harmony Biosciences Holdings, Inc. has the higher composite rating of Strong Buy.

This comparison is algorithmically generated and is not financial advice.

MetricARWRHRMY
Scores & Fundamentals
Composite Score6.0/107.5/10▲
RatingConsider BuyStrong Buy▲
Price$66.56$42.06
P/E Ratio—15.5
ROE-0.3%18.6%▲
Market Cap$9B$2B
Fair Value——
Dividend Yield——
Sector Rank#50 of 168#5 of 168▲
Model Verdicts
PiotroskiAttractiveAttractive
BuffettNeutralAttractive▲
GrahamNeutralNeutral
LynchLimited DataStrong▲
GreenblattCautionStrong▲
View full ARWRanalysis →View full HRMYanalysis →

Related comparisons

ABBV vs ARWRARWR vs INCYABBV vs HRMYHRMY vs INCYHALO vs HRMYARWR vs AZNHRMY vs VAL
Compare any two stocks →

ARWR vs HRMY: Which Stock Scores Higher?

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) and Harmony Biosciences Holdings, Inc. (HRMY) are both in the Health Care sector. HRMY currently leads with a composite score of 7.5/10 (Strong Buy) compared to ARWR's 6.0/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer